Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II

January 31, 2011 By Bio-Medicine.Org

SHAWNEE, Kan., Jan. 31, 2011 /PRNewswire/ — Bayer Animal Health
announced this month at the North American Veterinary Conference,
the availability of its new products:  Advantage® II for
cats and dogs, and K9 Advantix® II for dogs.  These
products combine the adulticidal properties of the original
formulations of Advantage® Topical Solution and K9
Advantix®, with the insect growth regulator (IGR) pyriproxyfen,
which inhibits the development of flea eggs and kills flea larvae.
 As a result, Advantage® II and K9 Advantix® II kill
all flea life stages and prevent fleas on a treated dog from
infesting the home.  These products will be available in March
2011.  

Pyriproxyfen, the added compound in Advantage® II and K9
Advantix® II, interferes with the hormone signaling of growing
insects so that fleas in immature stages are unable to mature.
 The hormone pathway that pyriproxyfen targets is specific to
insects and does not affect mammals.  

“Adding pyriproxyfen to the original formulations of
Advantage® Topical Solution and K9 Advantix® gives an added
layer of protection to our customers’ pets and their pets’
surroundings.  It interrupts the flea life cycle at multiple
stages, and prevents reinfestation,” said Peter Ryan, Vice
President & Head, Companion Animal Business Unit, Bayer Animal
Health.

Advantage® II and K9 Advantix® II have adulticidal,
larvicidal and ovicidal properties, killing adult fleas and
preventing the emergence of new ones.  Disrupting the flea
life cycle through different active ingredients and modes of action
is often referred to as integrated flea control (IFC).
 Imidacloprid quickly paralyzes a flea’s mouthparts and kills
fleas through contact, so fleas don’t have to bite your pet to die.
By protecting pets from fleas, imidacloprid has been shown to
reduce the incidence of certain conditions including flea al

‘/>”/>

SOURCE

Related Articles Read More >

An illustration showing the Autus size-adjustable heart valve being expanded years after implantation with a minimally invasive balloon catheter.
The first-of-its-kind Autus pediatric heart valve is designed for expansion and durability
The MIT researcher's implant, LUCID.
MIT researchers design implantable ultrasound-powered drug delivery device to minimize tumor recurrence
An image of the Teleflex Freesolve RMS resorbable magnesium scaffold.
Teleflex Interventional leader sees resorbables as ‘the next frontier’ of PCI
Feminai's breast sensor patch
AdvaMed and MedTech Innovator name 2026 prize winners and finalists
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe